Comparison of causes of death using HEMO Study and HCFA end-stage renal disease death notification classification systems. The National Institutes of Health-funded Hemodialysis. Health Care Financing Administration.

Comparison of causes of death using HEMO Study and HCFA end-stage renal disease death notification classification systems. The National Institutes of Health-funded Hemodialysis. Health Care Financing Administration.

Item

http://www.wikidata.org/entity/Q34482868

Q34482868

about

Long-term Effects of Frequent Nocturnal Hemodialysis on Mortality: The Frequent Hemodialysis Network (FHN) Nocturnal Trial Antidepressants for treating depression in adults with end-stage kidney disease treated with dialysis High blood pressure in dialysis patients: cause, pathophysiology, influence on morbidity, mortality and management Association between serum 2-microglobulin level and infectious mortality in hemodialysis patients.Statistical analysis and design for estimating accuracy in clinical-center classification of cause-specific clinical events in clinical trials.Validation of CKD and related conditions in existing data sets: A systematic review.Design and implementation of the Canadian Kidney Disease Cohort Study (CKDCS): A prospective observational study of incident hemodialysis patients Systolic blood pressure and mortality in prevalent haemodialysis patients in the HEMO study Meeting KDOQI guideline goals at hemodialysis initiation and survival during the first year Mortality associated with low serum sodium concentration in maintenance hemodialysis.Markers of increased cardiovascular risk in patients with chronic kidney disease.Retained organic solutes, patient characteristics and all-cause and cardiovascular mortality in hemodialysis: results from the retained organic solutes and clinical outcomes (ROSCO) investigators Protein carbamylation is associated with heart failure and mortality in diabetic patients with end-stage renal disease.Improving ascertainment of sudden cardiac death in patients with end stage renal disease.Predictors of sudden cardiac death: a competing risk approach in the hemodialysis study Heritability of Risk for Sudden Cardiac Arrest in ESRD.Haemodialysis and peritoneal dialysis patients admitted to intensive care units.Immune Sensitization and Mortality in Wait-Listed Kidney Transplant Candidates.Prehemodialysis care by dietitians and first-year mortality after initiation of hemodialysis CT coronary angiography is feasible for the assessment of coronary artery disease in chronic dialysis patients, despite high average calcium scores.Cause-specific mortality of dialysis patients after coronary revascularization: why don't dialysis patients have better survival after coronary intervention?Cerebrovascular disease incidence, characteristics, and outcomes in patients initiating dialysis: the choices for healthy outcomes in caring for ESRD (CHOICE) study.Peripheral vascular disease-related procedures in dialysis patients: predictors and prognosis.Near-term prediction of sudden cardiac death in older hemodialysis patients using electronic health records Results of the HEMO Study suggest that p-cresol sulfate and indoxyl sulfate are not associated with cardiovascular outcomes.Sudden Cardiac Death Among Hemodialysis Patients.Serum Asymmetric and Symmetric Dimethylarginine and Morbidity and Mortality in Hemodialysis Patients.Trimethylamine N-Oxide and Cardiovascular Events in Hemodialysis Patients.Declining comorbidity-adjusted mortality rates in English patients receiving maintenance renal replacement therapy.Change in cardiovascular disease status in peritoneal dialysis patients: a 5-year single-center experience.Disparities in early mortality among chronic kidney disease patients who transition to peritoneal dialysis and hemodialysis with and without catheters.Inpatient hemodialysis initiation: reasons, risk factors and outcomes.

P2860

Q24289294-1B7FD1C9-1FF1-485A-92D8-771EA8BBC042 Q26471942-14BBA2E9-7D81-4734-8AE9-A6C52EC05DB4 Q26861624-6EDC0BA6-3A06-4955-A6D8-24AC28C173BE Q30440532-F6FAB583-84A8-4995-B4EC-813EB245965A Q30454523-0ED91973-210E-4186-88EA-982ECF85B257 Q33652007-4047A810-91EE-445F-B6E9-EF13DBF63CEE Q33821580-0E16676F-7380-4E97-AB9F-8B1FF48B26F3 Q33860241-96505F22-8186-431B-8F6C-64AF967971ED Q34281463-A645858B-E15F-4BFB-AAF8-4C7038079A04 Q34580775-A234F485-5D5F-48FA-AE90-7CFAA2747F66 Q34582124-5491F8FC-C9D2-4E6E-9440-43A847C7DFB2 Q34785990-92D01CB8-3154-47A8-912A-6E69268A542A Q35667666-5BEBD93C-9119-47C8-A9F8-8A8D9E4E4683 Q35692484-771B4012-43FD-4AC8-9509-C348CA538241 Q35692508-FAB84396-3CC3-4E35-A5AF-7BAF5EE8BF98 Q36223335-02602590-A06A-43FC-B91C-DE20FC4375A4 Q36392437-B94073D5-DE61-456B-8D81-77C6A77364BF Q36514884-3ECD1D45-CBD3-4E82-A986-0A93EB649A9C Q36940300-AFC77E46-3F44-413C-887D-A3DBEEBDEB13 Q37001063-82DCF78E-36B4-4995-9A22-D70553820BA8 Q37306316-5B019639-473C-4430-A193-F9DDD0F7F969 Q37347775-A56DFB00-B8F0-4A45-B4F9-38D154266D5E Q37378441-792321B0-B069-40F8-AC35-14CD586E797D Q37426950-9227C603-F6C5-46BC-9EC6-14AEF4E282A7 Q38664089-0DB0D42B-05AE-4229-8394-CB537F235FE1 Q39145628-7EFC4C37-F8BC-4CD6-8233-BD9EB2D74DBF Q40380245-1F30A8B2-959E-45B2-8B66-20548A8615F0 Q40642197-87002F1C-0B0E-4452-8098-FA145C419407 Q50067304-1AC62236-5984-4B56-BD5B-BE99E93827FC Q50991537-A5D8456F-3DA5-44EB-BAA3-246FE37CD761 Q52659016-FE6AB3F3-13D9-430D-8C66-6456707CC9E5 Q55397420-E893717A-B68F-48A5-82CE-C8445CF3A891

P2860

Comparison of causes of death using HEMO Study and HCFA end-stage renal disease death notification classification systems. The National Institutes of Health-funded Hemodialysis. Health Care Financing Administration.

Item

http://www.wikidata.org/entity/Q34482868

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu